COGT vs REG · $5.75B cap vs P/E 34, rev $1.45B
Cogent Biosciences Inc (COGT) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Cogent Biosciences Inc (COGT) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
COGT does not have a complete income-statement cache yet.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
COGT currently screens at market cap $5.75B. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the COGT and REG stock pages for the full models.
Not investment advice.